Annotation Detail

Information
Associated Genes
KIT
Associated Variants
KIT p.Ala503_Tyr504insAlaTyr (p.A503_Y504insAY) ( ENST00000288135.6, ENST00000412167.7, ENST00000686011.1, ENST00000687109.1, ENST00000687246.1, ENST00000687295.1, ENST00000689832.1, ENST00000689994.1, ENST00000690543.1, ENST00000692783.1 )
KIT p.Ala503_Tyr504insAlaTyr (p.A503_Y504insAY) ( ENST00000288135.6, ENST00000412167.7, ENST00000686011.1, ENST00000687109.1, ENST00000687246.1, ENST00000687295.1, ENST00000689832.1, ENST00000689994.1, ENST00000690543.1, ENST00000692783.1 )
Associated Disease
cancer
Source Database
CIViC Evidence
Description
In an in vitro study, Chinese hamster ovary cells expressing KIT A502_Y503INSAY demonstrated comparable sensitivity to sunitinib treatment compared to CHO cells expressing ligand activated wild-type KIT (IC50<100 nmol/L). Sensitivity was determined by assessing KIT auto-phosphorylation.
Variant Origin
somatic
Variant Origin
Somatic
Evidence URL
https://civic.genome.wustl.edu/links/evidence_items/4100
Gene URL
https://civic.genome.wustl.edu/links/genes/29
Variant URL
https://civic.genome.wustl.edu/links/variants/1558
Rating
2
Evidence Type
Predictive
Disease
Cancer
Evidence Direction
Does Not Support
Drug
Sunitinib
Evidence Level
D
Clinical Significance
Resistance
Pubmed
18955458
Drugs
Drug NameSensitivitySupported
SunitinibResitance or Non-Reponsefalse